BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27877888)

  • 21. Versatile synthesis of end-reactive polyrotaxanes applicable to fabrication of supramolecular biomaterials.
    Tamura A; Tonegawa A; Arisaka Y; Yui N
    Beilstein J Org Chem; 2016; 12():2883-2892. PubMed ID: 28144361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scavenger Receptor A-Mediated Targeting of Carboxylated Polyrotaxanes to Macrophages and the Impacts of Supramolecular Structure.
    Matsui H; Tamura A; Osawa M; Tonegawa A; Arisaka Y; Matsumura M; Miura H; Yui N
    Macromol Biosci; 2018 Aug; 18(8):e1800059. PubMed ID: 29900668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitigating RANKL-induced cholesterol overload in macrophages with β-cyclodextrin-threaded polyrotaxanes suppresses osteoclastogenesis.
    Zhu H; Tamura A; Zhang S; Terauchi M; Yoda T; Yui N
    Biomater Sci; 2022 Sep; 10(18):5230-5242. PubMed ID: 35904082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticles assembled via pH-responsive reversible segregation of cyclodextrins in polyrotaxanes.
    Tardy BL; Tan S; Dam HH; Ejima H; Blencowe A; Qiao GG; Caruso F
    Nanoscale; 2016 Aug; 8(34):15589-96. PubMed ID: 27509868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ER stress-mediated autophagic cell death induction through methylated β-cyclodextrins-threaded acid-labile polyrotaxanes.
    Nishida K; Tamura A; Yui N
    J Control Release; 2018 Apr; 275():20-31. PubMed ID: 29428200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C.
    Yasmin N; Ishitsuka Y; Fukaura M; Yamada Y; Nakahara S; Ishii A; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Okada Y; Nishikawa J; Ichikawa A; Iohara D; Hirayama F; Higaki K; Ohno K; Matsuo M; Irie T
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human iPSC-derived inducible neuronal model of Niemann-Pick disease, type C1.
    Prabhu AV; Kang I; De Pace R; Wassif CA; Fujiwara H; Kell P; Jiang X; Ory DS; Bonifacino JS; Ward ME; Porter FD
    BMC Biol; 2021 Oct; 19(1):218. PubMed ID: 34592985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylation of Cyclodextrin-Threaded Polyrotaxanes Yields Temperature-Responsive Phase Transition and Coacervate Formation Properties.
    Tonegawa A; Tamura A; Yui N
    Macromol Rapid Commun; 2020 Sep; 41(17):e2000322. PubMed ID: 32767501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in
    Hoque S; Kondo Y; Sakata N; Yamada Y; Fukaura M; Higashi T; Motoyama K; Arima H; Higaki K; Hayashi A; Komiya T; Ishitsuka Y; Irie T
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy.
    Yu D; Swaroop M; Wang M; Baxa U; Yang R; Yan Y; Coksaygan T; DeTolla L; Marugan JJ; Austin CP; McKew JC; Gong DW; Zheng W
    J Biomol Screen; 2014 Sep; 19(8):1164-73. PubMed ID: 24907126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of redox imbalance and mitochondrial dysfunction in Niemann-Pick type C 1 patients: the in vitro effect of combined therapy with antioxidants and β-cyclodextrin nanoparticles.
    Hammerschmidt TG; Donida B; Raabe M; Faverzani JL; de Fátima Lopes F; Machado AZ; Kessler RG; Reinhardt LS; Poletto F; Moura DJ; Vargas CR
    Metab Brain Dis; 2023 Feb; 38(2):507-518. PubMed ID: 36447062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Niemann-Pick C1 protein: obligatory roles for N-terminal domains and lysosomal targeting in cholesterol mobilization.
    Watari H; Blanchette-Mackie EJ; Dwyer NK; Glick JM; Patel S; Neufeld EB; Brady RO; Pentchev PG; Strauss JF
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):805-10. PubMed ID: 9927649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of 2-hydroxypropyl-β-cyclodextrin/pluronic-based polyrotaxanes via heterogeneous reaction as potential Niemann-Pick type C therapeutics.
    Mondjinou YA; McCauliff LA; Kulkarni A; Paul L; Hyun SH; Zhang Z; Wu Z; Wirth M; Storch J; Thompson DH
    Biomacromolecules; 2013 Dec; 14(12):4189-97. PubMed ID: 24180231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein.
    Boadu E; Nelson RC; Francis GA
    Biochim Biophys Acta; 2012 Mar; 1821(3):396-404. PubMed ID: 22179027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann-Pick disease type C treatment.
    Yamada Y; Fukaura-Nishizawa M; Nishiyama A; Ishii A; Kawata T; Shirakawa A; Tanaka M; Kondo Y; Takeo T; Nakagata N; Miwa T; Takeda H; Orita Y; Motoyama K; Higashi T; Arima H; Seki T; Kurauchi Y; Katsuki H; Higaki K; Minami K; Yoshikawa N; Ikeda R; Matsuo M; Irie T; Ishitsuka Y
    Clin Transl Med; 2023 Aug; 13(8):e1350. PubMed ID: 37620691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Threaded macromolecules as a versatile framework for biomaterials.
    Tamura A; Yui N
    Chem Commun (Camb); 2014 Nov; 50(88):13433-46. PubMed ID: 25036737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells.
    Rosenbaum AI; Zhang G; Warren JD; Maxfield FR
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5477-82. PubMed ID: 20212119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclodextrins applied to the treatment of lysosomal storage disorders.
    Ishitsuka Y; Irie T; Matsuo M
    Adv Drug Deliv Rev; 2022 Dec; 191():114617. PubMed ID: 36356931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: Results of an international 48-week Phase I/II trial.
    Sharma R; Hastings C; Staretz-Chacham O; Raiman J; Paucar M; Spiegel R; Murray B; Hurst B; Liu B; Kjems L; Hrynkow S
    Mol Genet Metab Rep; 2023 Sep; 36():100988. PubMed ID: 37670901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization, and evaluation of pluronic-based β-cyclodextrin polyrotaxanes for mobilization of accumulated cholesterol from Niemann-Pick type C fibroblasts.
    Collins CJ; McCauliff LA; Hyun SH; Zhang Z; Paul LN; Kulkarni A; Zick K; Wirth M; Storch J; Thompson DH
    Biochemistry; 2013 May; 52(19):3242-53. PubMed ID: 23560535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.